REPRISE BIOMEDICAL, INC.

Profile

Company Names

REPRISE BIOMEDICAL, INC.

Addresses

17400 MEDINA RD., STE. 100, PLYMOUTH, MN 55447

17400 MEDINA ROAD, SUITE 100, PLYMOUTH, MN 55447

17400 MEDINA RD STE 100, PLYMOUTH, MN 55447

17400 MEDINA RD, STE 100, PLYMOUTH, MN 55447

17400 MEDINA RD, SUITE 100, PLYMOUTH, MN 55447

10399 WEST 70TH STREET, EDEN PRAIRIE, MN 55344

Phone Numbers

763-284-6780
7632846780
763-360-7165

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

MINNESOTA

Total Amount Raised:

$56,377,862.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2026-05-14 
$9,246,100.00 
$10,000,000.00 
$753,900.00 
Equity 
5
2025-06-26 
$6,356,956.00 
$7,000,000.00 
$643,044.00 
Equity 
4
2023-10-19 
$7,982,500.00 
$12,500,000.00 
$4,517,500.00 
Equity 
3
2022-12-20 
$15,297,306.00 
$15,297,306.00 
$0.00 
Equity 
2
2020-11-13 
$4,995,000.00 
$5,000,000.00 
$5,000.00 
Equity 
1
2019-06-28 
$12,500,000.00 
$12,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFF 
 
DUNCAN 
EXECUTIVE OFFICER
REPRISE BIOMEDICAL, INC.
RONALD 
 
EIBENSTEINER 
DIRECTOR
MIROMATRIX MEDICAL INC.   |  MAX4G, INC.   |  KWIKBIT INC.   |  REPRISE BIOMEDICAL, INC.
JAKE 
 
ISENBURG 
EXECUTIVE OFFICER
REPRISE BIOMEDICAL, INC.
STEVE 
 
JAGODZINSKI 
EXECUTIVE OFFICER
REPRISE BIOMEDICAL, INC.
ERWIN 
 
KELEN 
DIRECTOR
MIKROBEX INC.   |  READY CREDIT CORP   |  REBIOTIX INC.   |  KWIKBIT INC.   |  REPRISE BIOMEDICAL, INC.   |  ALERAN SOFTWARE, INC.
HEATHER 
 
KOTILA 
EXECUTIVE OFFICER
REPRISE BIOMEDICAL, INC.
TOM 
 
KOUCHOUKOS 
EXECUTIVE OFFICER
REPRISE BIOMEDICAL, INC.
JERROD 
 
KRUEGER 
EXECUTIVE OFFICER
REPRISE BIOMEDICAL, INC.
PHIL 
 
NALBONE 
DIRECTOR
REPRISE BIOMEDICAL, INC.
PHILLIP 
 
NALBONE 
DIRECTOR
REPRISE BIOMEDICAL, INC.
CARRIE 
 
POWERS 
EXECUTIVE OFFICER, DIRECTOR
REPRISE BIOMEDICAL, INC.
HOWARD 
 
ROOT 
DIRECTOR, EXECUTIVE OFFICER
REPRISE BIOMEDICAL, INC.
JEFF 
 
ROSS 
DIRECTOR
RIOCAN HOLDINGS USA INC.   |  MIROMATRIX MEDICAL INC.   |  REPRISE BIOMEDICAL, INC.   |  NEXAMP, INC.   |  LUMINARY THERAPEUTICS, INC.
GREG 
 
SMOCK 
EXECUTIVE OFFICER
REPRISE BIOMEDICAL, INC.
TINA 
 
WALTERS 
EXECUTIVE OFFICER
WMHIP, LLC   |  DH OZ FUND, LLC   |  DH QOZB, LLC   |  BUNSEN INVESTORS, LLC   |  BUNSEN INVESTORS II, LLC   |  REPRISE BIOMEDICAL, INC.
ALAN 
 
WOLDT 
DIRECTOR
REPRISE BIOMEDICAL, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-07-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-05-14 
2026-05-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-05-14 
2025-07-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-06-26 
2023-12-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-19 
2023-11-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-19 
2023-01-25
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-20 
2023-01-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-20 
2021-03-31
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-13 
2020-11-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-13 
2019-07-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-06-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
CEDAR POINT CAPITAL, LLC
145116
CEDAR POINT CAPITAL, LLC
145116
CEDAR POINT CAPITAL, LLC
145116
CEDAR POINT CAPITAL, LLC
NONE